FDA has approved another ustekinumab biosimilar (Wezlana) as being interchangeable for use in adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. https://t.co/zbQKjmKgZh https://t.co/UuTDRgCBIV
Links:
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases
https://bit.ly/3tZFdo4
02-11-2023